Conversely, FTO erases m6A modifications on metastasis-associated protein 1 (MTA1) mRNA and lowers the stability of MTA1 transcripts mediated by IGF2BP2, leading to the suppression of metastasis in CRC [89]. This evidence concerns the gene MTA1 and colorectal carcinoma.